查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715538

静脉通路装置市场按类型、年龄层、最终用户和应用划分－2025-2030 年全球预测

Vascular Access Device Market by Type, Age Group, End User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

静脉通路装置市场预计到 2024 年将达到 51.1 亿美元，到 2025 年将达到 54.8 亿美元，到 2030 年将达到 79.8 亿美元，复合年增长率为 7.71%。

主要市场统计数据
基准年2024年 51.1亿美元
预计年份：2025年 54.8亿美元
预测年份 2030 79.8亿美元
复合年增长率（%） 7.71%

在当今动态的医疗保健环境中，静脉通路装置市场越来越被认为是高效率医疗服务的关键组成部分。静脉通路装置（例如中央静脉导管和静脉通路装置）的使用范围不断扩大，凸显了对强大、可靠和适应性强的医疗解决方案的需求。这些仪器在各种治疗和诊断应用中至关重要，确保患者在从医院到居家医疗的过程中得到有效和安全的治疗。

医疗保健组织不断寻求创新，不仅要改善病患的治疗效果，还要简化临床流程。随着程式的发展，这些仪器的技术也变得越来越复杂。新材料、先进导管设计和改进的生物相容性的整合使製造商能够满足安全性和性能的双重需求。市场领导表现出对研发的强烈承诺，反映了整个产业朝向基于价值的医疗保健发展的趋势。

全球向微创手术的转变以及对门诊治疗的偏好增加进一步影响了市场的发展。这种转变得益于穿戴式科技和远端监控的发展，为病患管理框架增加了新的弹性和适应性。总体而言，当前的情况以创新、策略合作和对卓越患者照护的不懈追求为特征。

变革性变化重新定义静脉通路装置格局

近年来，在科技的快速进步和患者照护模式不断发展的推动下，静脉通路装置市场发生了变化。新产品创新带来了突破性的设计改进，同时优先考虑功能性和病人安全。随着效能指标和成本效率的提高，製造商正在从传统模式转向采用整合监控和即时数据分析的设计。

医疗保健提供者越来越多地采用能够提高手术准确性、降低併发症发生率并有助于改善患者治疗效果的设备。这些转变不仅涉及产品属性，还反映了更广泛的系统转型，包括简化供应链、医院系统的数位整合以及对个人化护理的关注。随着市场扩大，实证实践被采用，创新步伐加快。此外，监管实践中的新兴趋势促进了行业内持续品质改进的文化，推动了标准化和加强安全通讯协定。

製造商和相关人员目前正在利用材料科学、动态和即时监控方面的进步来确保所有设备在不同的临床场景中都能发挥最佳性能。这些进步不仅使市场在技术层面上具有竞争力，而且在适应不断变化的患者人口结构和医疗保健提供模式方面也更具弹性。

详细的市场细分洞察

市场区隔洞察揭示了血管通路设备产业动态背后的复杂方面。按类型进行的分析包括对中央静脉导管和静脉通路装置的全面审查，以及对週边静脉导管（长）和周边静脉导管（短）的详细审查。这种细緻的分类有助于识别每种类型的设备使用模式和技术进步趋势。年龄细分涵盖成人、老年和儿科，全面了解患者在整个生命週期中的独特需求和挑战。

此外，依最终使用者细分的重点是门诊手术中心、居家医疗环境、医院和诊所等环境，突显这些环境独有的不同临床要求和程序标准。分析框架扩展到输血、诊断和测试以及药物管理等应用。药物管理重点在于静脉注射抗生素和化疗，以便更好地了解市场对专门治疗方案的需求。这种综合细分方法使相关人员能够根据不同细分市场的需求制定策略，并确保产品和服务满足多样化且日益复杂的客户群的期望。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 慢性病的增多使得长期血管通路解决方案的需求持续存在。
      • 需要静脉通路装置进行液体管理的外科手术增多
    • 限制因素
      • 高成本、报销问题和重大产品召回
    • 机会
      • 开发创新抗菌涂层技术以减少设备相关感染
      • 居家医疗领域的扩张正在推动对可携式和易于使用的血管设备的需求
    • 任务
      • VAD 相关併发症和感染疾病风险以及监管障碍
  • 市场区隔分析
    • 类型：急性护理中周边静脉通路装置的采用日益增多
    • 最终用户：住院和门诊病人手术量的增加将推动医院和诊所更多地使用静脉通路装置
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章静脉通路装置市场（按类型）

  • 介绍
  • 中央静脉导管
  • 静脉通路装置
    • 长週边静脉导管
    • 短週边静脉导管

第七章静脉通路装置市场（依年龄层）

  • 介绍
  • 成人
  • 老年人
  • 孩子们

第 8 章静脉通路装置市场（依最终用户）

  • 介绍
  • 门诊手术中心
  • 居家医疗环境
  • 医院和诊所

第九章静脉通路装置市场（依应用）

  • 介绍
  • 输血
  • 诊断和检测
  • 药物管理
    • 抗生素输注
    • 化疗

10. 美洲静脉通路装置市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

11. 亚太地区静脉通路装置市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

12. 欧洲、中东和非洲静脉通路装置市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • 3M Company
  • Access Vascular, Inc.
  • AMECATH
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cook Medical, Inc.
  • Edwards Lifesciences Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Fujifilm Sonosite, Inc.
  • ICU Medical, Inc.
  • Kimal PLC
  • Medical Components, Inc.
  • Medtronic PLC
  • Nipro Medical Corporation
  • Prodimed
  • Semler Technologies Inc.
  • Siemens Healthcare AG
  • Smiths Medical, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Versago Vascular Access
  • Vygon SA
  • WL Gore & Associates, Inc
Product Code: MRR-034B50030371

The Vascular Access Device Market was valued at USD 5.11 billion in 2024 and is projected to grow to USD 5.48 billion in 2025, with a CAGR of 7.71%, reaching USD 7.98 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 5.11 billion
Estimated Year [2025] USD 5.48 billion
Forecast Year [2030] USD 7.98 billion
CAGR (%) 7.71%

In today's dynamic healthcare environment, the vascular access device market is increasingly recognized as a critical component in the delivery of efficient care. The expanding use of vascular access devices such as central venous catheters and peripheral vascular access devices underlines the need for robust, reliable, and adaptable medical solutions. These devices are pivotal in a variety of treatments and diagnostic applications, ensuring that patients receive therapies effectively and safely in settings ranging from hospitals to home healthcare.

Healthcare organizations continually seek innovations that not only offer improved patient outcomes but also streamline clinical processes. As procedures have evolved, so has the technical sophistication of these devices. The integration of new materials, advanced catheter designs, and enhanced biocompatibility has helped manufacturers meet the dual demand for safety and performance. Market leaders have demonstrated a strong commitment to research and development, reflecting the broader industry trend towards value-based care.

The market's evolution is further shaped by a global shift towards minimally invasive treatments and a higher preference for outpatient care. This transformation is supported by developments in wearable technologies and remote monitoring, adding another layer of resilience and adaptability to patient management frameworks. Overall, the current landscape is marked by innovation, strategic collaborations, and a relentless drive towards excellence in patient care.

Transformative Shifts Redefining the Vascular Access Device Landscape

Recent years have witnessed transformative shifts in the vascular access device market, driven by rapid technological advancements and an evolving patient care paradigm. New product innovations have brought revolutionary design improvements that emphasize both functionality and patient safety. As performance metrics advance alongside cost efficiencies, producers are transitioning from traditional models to designs that incorporate integrated monitoring and real-time data analytics.

Healthcare providers are increasingly adopting devices that enhance procedural accuracy, reduce complication rates, and contribute to better patient outcomes. These shifts are not merely limited to product attributes; they are reflective of broader systemic transformations, including streamlined supply chains, digital integration in hospital systems, and an emphasis on personalized care. As the market has expanded, the adoption of evidence-based practices has facilitated a faster pace of innovation. Additionally, emerging trends in regulatory practices have encouraged a culture of continuous quality improvement within the industry, promoting enhanced standardization and safety protocols.

Manufacturers and stakeholders are now leveraging advancements in material science, fluid dynamics, and real-time monitoring to ensure that every device performs optimally in diverse clinical scenarios. This evolution has resulted in a market that is not only competitive on the basis of technology but also resilient in the face of ever-changing patient demographics and healthcare delivery models.

Insights Through Detailed Market Segmentation

The market segmentation insights reveal intricate aspects that underpin the dynamics of the vascular access device industry. Analysis based on type shows a thorough study across central venous catheters and peripheral vascular access devices, with further scrutiny into long peripheral intravenous catheters and short peripheral intravenous catheters. This nuanced categorization helps identify trends in device usage patterns and technological advancements specific to each type. The segmentation based on age groups targets adult, geriatric, and pediatric populations, providing a comprehensive look at patient-specific needs and challenges across life spans.

Furthermore, segmentation by end user emphasizes settings such as ambulatory surgical centers, home healthcare environments, and hospitals and clinics, which underscores the varied clinical requirements and procedural standards inherent in these settings. The analytical framework is extended to applications that include blood transfusion, diagnostics and testing, and drug administration. In drug administration, the focus on antibiotic infusion and chemotherapy facilitates a better understanding of market demand in specialized treatment protocols. This integrative segmentation approach enables stakeholders to tailor strategies that precisely align with the needs of diverse segments, ensuring that products and services meet the expectations of a broad and increasingly complex customer base.

Based on Type, market is studied across Central Venous Catheters and Peripheral Vascular Access Devices. The Peripheral Vascular Access Devices is further studied across Long Peripheral Intravenous Catheter and Short Peripheral Intravenous Catheter.

Based on Age Group, market is studied across Adult, Geriatric, and Pediatric.

Based on End User, market is studied across Ambulatory Surgical Centers, Home Healthcare Settings, and Hospitals & Clinics.

Based on Application, market is studied across Blood Transfusion, Diagnostics & Testing, and Drug Administration. The Drug Administration is further studied across Antibiotic Infusion and Chemotherapy.

Regional Trends and Their Impact on Market Dynamics

A regional perspective provides valuable insight into the growing demand and unique opportunities within the vascular access device market. Detailed exploration of major regions such as the Americas, Europe, Middle East & Africa, and Asia-Pacific highlights the differing market maturity levels and regulatory frameworks that influence device adoption. The Americas continue to lead in terms of advanced healthcare infrastructure and high rates of technology integration. In contrast, Europe, Middle East & Africa is witnessing rapid modernization of healthcare systems with a pronounced emphasis on safety and efficiency standards. Meanwhile, the Asia-Pacific region, characterized by emerging economies and a growing middle class, is experiencing significant growth driven by increased investments in healthcare facilities and technology.

These regional insights help clarify how demographic shifts, economic development, and local healthcare policies shape the competitive landscape and fuel demand for innovative vascular access solutions. Understanding these dynamics is critical for stakeholders aiming to optimize market penetration strategies, whether by addressing regulatory challenges or capitalizing on regions with high growth potential.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Insights from Industry Leaders and Major Market Players

A closer examination of the competitive environment reveals that a host of influential companies are shaping the vascular access device market. Industry giants such as 3M Company, Access Vascular, Inc., AMECATH, AngioDynamics, Inc., and Argon Medical Devices, Inc. have established significant footholds in the market through continuous innovation and strategic positioning. These companies, along with notable players including Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., and Becton, Dickinson and Company, play pivotal roles in driving advancements in technology and patient care standards.

Leading organizations such as Cook Medical, Inc., Edwards Lifesciences Corporation, Fresenius Medical Care AG & Co. KGaA, Fujifilm Sonosite, Inc., and ICU Medical, Inc. have excelled in developing products that address both clinical efficacy and ease of use. The landscape is further enriched by the contributions of Kimal PLC, Medical Components, Inc., Medtronic PLC, Nipro Medical Corporation, and Prodimed, whose expertise helps set rigorous quality benchmarks. Additional market influencers like Semler Technologies Inc., Siemens Healthcare AG, Smiths Medical, Inc., Teleflex Incorporated, Terumo Corporation, Versago Vascular Access, Vygon SA, and W. L. Gore & Associates, Inc. strengthen the market's competitive edge. Analyzing the strategic moves and innovations of these companies provides a comprehensive understanding of market trends, competitive intensity, and future growth prospects.

The report delves into recent significant developments in the Vascular Access Device Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Access Vascular, Inc., AMECATH, AngioDynamics, Inc., Argon Medical Devices, Inc., Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, Cook Medical, Inc., Edwards Lifesciences Corporation, Fresenius Medical Care AG & Co. KGaA, Fujifilm Sonosite, Inc., ICU Medical, Inc., Kimal PLC, Medical Components, Inc., Medtronic PLC, Nipro Medical Corporation, Prodimed, Semler Technologies Inc., Siemens Healthcare AG, Smiths Medical, Inc., Teleflex Incorporated, Terumo Corporation, Versago Vascular Access, Vygon SA, and W. L. Gore & Associates, Inc. Strategic Recommendations for Market Leaders

For industry leaders charting the future, a combination of innovation, collaboration, and adaptation is paramount. Leaders are encouraged to invest in advanced research and development efforts to foster the creation of next-generation vascular access devices that combine efficiency with enhanced patient safety profiles. By integrating emerging technologies such as digital health monitoring and real-time analytics into product portfolios, companies can stay ahead of the demand curve and meet evolving clinical requirements.

Additionally, focusing on expanding geographic reach while localizing product offerings to address regional nuances can vastly improve market penetration. Companies should also consider forming strategic partnerships with regional healthcare providers and technology firms to facilitate smoother product rollouts and service adoption. Embracing collaborative ecosystems enables the leveraging of shared expertise, a critical factor in accelerating product innovation and addressing global regulatory challenges.

Finally, maintaining agility in response to shifting market demographics and treatment paradigms is essential. Industry leaders must continuously reassess their strategies to ensure alignment with the rapid pace of technological advancement and the evolving demands of diverse healthcare settings.

Conclusion: The Road Ahead for Vascular Access Devices

In summary, the vascular access device market is in a state of significant evolution, marked by rapid technological progress and a shifting landscape driven by global demographics and healthcare imperatives. The integration of robust segmentation insights and regional trends highlights the multifaceted nature of market demand, while the competitive actions of established industry players underscore the importance of innovation and strategic foresight. As new standards in patient care continue to emerge, stakeholders are presented with abundant opportunities to refine their approaches and drive value across clinical settings.

The future trajectory of this market hinges on the collective ability to meet sophisticated patient needs, streamline clinical operations, and adopt agile strategies that respond to an ever-changing healthcare environment. A proactive stance today will pave the way for greater advancements in safety, precision, and overall patient outcomes tomorrow.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising cases of chronic illnesses create sustained need for long-term vascular access solutions
      • 5.1.1.2. Increasing number of surgical procedures requiring vascular access devices for fluid administration
    • 5.1.2. Restraints
      • 5.1.2.1. High costs and reimbursement issues along with significant product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Developing innovative antimicrobial coating technologies to reduce device-related infections
      • 5.1.3.2. Expanding home healthcare sector is increasing the need for portable and user-friendly vascular devices
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of complications and infections associated with VADs along with regulatory hurdles
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Burgeoning adoption of peripheral vascular access devices for short-term therapy
    • 5.2.2. End User: Expanding utilization of vascular-access-devices by hospitals and clinics owing to their high volume of inpatient and outpatient procedures
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vascular Access Device Market, by Type

  • 6.1. Introduction
  • 6.2. Central Venous Catheters
  • 6.3. Peripheral Vascular Access Devices
    • 6.3.1. Long Peripheral Intravenous Catheter
    • 6.3.2. Short Peripheral Intravenous Catheter

7. Vascular Access Device Market, by Age Group

  • 7.1. Introduction
  • 7.2. Adult
  • 7.3. Geriatric
  • 7.4. Pediatric

8. Vascular Access Device Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Home Healthcare Settings
  • 8.4. Hospitals & Clinics

9. Vascular Access Device Market, by Application

  • 9.1. Introduction
  • 9.2. Blood Transfusion
  • 9.3. Diagnostics & Testing
  • 9.4. Drug Administration
    • 9.4.1. Antibiotic Infusion
    • 9.4.2. Chemotherapy

10. Americas Vascular Access Device Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Vascular Access Device Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Vascular Access Device Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. BD develops enhanced system for immediate IV access in emergencies
    • 13.3.2. Teleflex transform vascular access with new Arrow VPS Rhythm DLX and NaviCurve in Canada
    • 13.3.3. Access Vascular partners with Capstone for expansion
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Access Vascular, Inc.
  • 3. AMECATH
  • 4. AngioDynamics, Inc.
  • 5. Argon Medical Devices, Inc.
  • 6. Asahi Kasei Medical Co., Ltd.
  • 7. B. Braun Melsungen AG
  • 8. Baxter International Inc.
  • 9. Becton, Dickinson and Company
  • 10. Cook Medical, Inc.
  • 11. Edwards Lifesciences Corporation
  • 12. Fresenius Medical Care AG & Co. KGaA
  • 13. Fujifilm Sonosite, Inc.
  • 14. ICU Medical, Inc.
  • 15. Kimal PLC
  • 16. Medical Components, Inc.
  • 17. Medtronic PLC
  • 18. Nipro Medical Corporation
  • 19. Prodimed
  • 20. Semler Technologies Inc.
  • 21. Siemens Healthcare AG
  • 22. Smiths Medical, Inc.
  • 23. Teleflex Incorporated
  • 24. Terumo Corporation
  • 25. Versago Vascular Access
  • 26. Vygon SA
  • 27. W. L. Gore & Associates, Inc

LIST OF FIGURES

  • FIGURE 1. VASCULAR ACCESS DEVICE MARKET MULTI-CURRENCY
  • FIGURE 2. VASCULAR ACCESS DEVICE MARKET MULTI-LANGUAGE
  • FIGURE 3. VASCULAR ACCESS DEVICE MARKET RESEARCH PROCESS
  • FIGURE 4. VASCULAR ACCESS DEVICE MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. VASCULAR ACCESS DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. VASCULAR ACCESS DEVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VASCULAR ACCESS DEVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VASCULAR ACCESS DEVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CENTRAL VENOUS CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY LONG PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY SHORT PERIPHERAL INTRAVENOUS CATHETER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY BLOOD TRANSFUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DIAGNOSTICS & TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY ANTIBIOTIC INFUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES VASCULAR ACCESS DEVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. MALAYSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 105. MALAYSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 109. PHILIPPINES VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. PHILIPPINES VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. SINGAPORE VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. SINGAPORE VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. SINGAPORE VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. TAIWAN VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. TAIWAN VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 129. TAIWAN VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. THAILAND VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. THAILAND VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 135. THAILAND VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. VIETNAM VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. VIETNAM VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 141. VIETNAM VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 152. DENMARK VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. DENMARK VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. DENMARK VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. EGYPT VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. EGYPT VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 160. EGYPT VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. FINLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. FINLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 166. FINLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 170. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 176. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 182. ISRAEL VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. ISRAEL VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 184. ISRAEL VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. NETHERLANDS VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. NETHERLANDS VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 196. NETHERLANDS VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 200. NIGERIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. NIGERIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 202. NIGERIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 260. TURKEY VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. TURKEY VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 262. TURKEY VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED ARAB EMIRATES VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED ARAB EMIRATES VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED ARAB EMIRATES VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY PERIPHERAL VASCULAR ACCESS DEVICES, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM VASCULAR ACCESS DEVICE MARKET SIZE, BY DRUG ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 278. VASCULAR ACCESS DEVICE MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 279. VASCULAR ACCESS DEVICE MARKET, FPNV POSITIONING MATRIX, 2024